Florida / New York / No Carolina
Ph: 561.316.3330

NeuroLogica’s OmniTom® Elite CT Scanner Now Available – See it at RSNA 2021

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • “The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department,” said David Webster, Chief Operating Officer of NeuroLogica.
  • “It is truly a facility-wide solution that decreases the time it takes to diagnose and initiate treatment for patients in need of care.
  • Battery operated and chargeable in a standard wall outlet, allows for continued use throughout the facility.

NeuroLogica’s next-generation multi-slice, small-bore, mobile OmniTom® Elite, which delivers high-quality point-of-care CT imaging, is released for sale in the USA.

“The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department,” said David Webster, Chief Operating Officer of NeuroLogica. “It is truly a facility-wide solution that decreases the time it takes to diagnose and initiate treatment for patients in need of care.”

Expanding on the benefits of its predecessor, the OmniTom Elite includes:

  • Improved omni-wheel design contributes to durability through transport as well as 360-degree mobility
  • An integrated drive system with drive camera and audio/visual sensors facilitates unimpeded movement through the facility
  • SmartAlign auto-alignment feature streamlines scanner-to-patient bed alignment which is instrumental in restricted spaces
  • Battery operated and chargeable in a standard wall outlet, allows for continued use throughout the facility
  • Integrated shielding to increase durability and protect staff
  • An ergonomic design with wireless tablet control designed with a single user in mind
  • Mobile Stroke Unit configuration, for use with emergency vehicles

In addition to the OmniTom Elite, NeuroLogica will also be showcasing its BodyTom 64 (510k pending) large bore scanner; the first ever mobile 64 slice whole body CT.

More on their visibility at RSNA can be found here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Sphere Fluidics Awarded Gold Accreditation by Investors in People

Dale Levitzke, CEO of Sphere Fluidics, expressed his pride in the achievement: "Receiving the Gold Investors in People Award is a significant milestone for Sphere Fluidics. It recognizes the dedication and hard work of our entire team in creating a workplace where people feel valued, supported, and empowered to reach their full potential. This award is not just a tribute to our HR practices, but a testament to our commitment to nurturing a culture of excellence and continuous improvement."

Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership

Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, and Takara Bio USA, Inc. (“Takara Bio USA”), a wholly-owned subsidiary of Takara Bio Inc., today announced the companies have settled their patent dispute and have partnered to bring together their combined foundational IP in the field of targeted depletion of undesired transcripts such as ribosomal RNAs from NGS...

CERo Therapeutics Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

CERo Therapeutics is continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA

By using this website you agree to accept Medical Device News Magazine Privacy Policy